[go: up one dir, main page]

MX2024002458A - Composicion de nebulizacion que comprende tiotropio y su metodo de administracion. - Google Patents

Composicion de nebulizacion que comprende tiotropio y su metodo de administracion.

Info

Publication number
MX2024002458A
MX2024002458A MX2024002458A MX2024002458A MX2024002458A MX 2024002458 A MX2024002458 A MX 2024002458A MX 2024002458 A MX2024002458 A MX 2024002458A MX 2024002458 A MX2024002458 A MX 2024002458A MX 2024002458 A MX2024002458 A MX 2024002458A
Authority
MX
Mexico
Prior art keywords
tiotropium
administration
nebulization composition
nebulization
composition
Prior art date
Application number
MX2024002458A
Other languages
English (en)
Spanish (es)
Inventor
Sunil Chaudhari
Suresh Rajurkar
Alkesh Kasliwal
Monika Tandon
Sushrut Kulkarni
Yogesh Patel
Original Assignee
Glenmark Specialty Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glenmark Specialty Sa filed Critical Glenmark Specialty Sa
Publication of MX2024002458A publication Critical patent/MX2024002458A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
MX2024002458A 2021-08-28 2022-08-28 Composicion de nebulizacion que comprende tiotropio y su metodo de administracion. MX2024002458A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN202121039037 2021-08-28
PCT/IB2022/058049 WO2023031753A2 (fr) 2021-08-28 2022-08-28 Composition de nébulisation comprenant du tiotropium et son procédé d'administration

Publications (1)

Publication Number Publication Date
MX2024002458A true MX2024002458A (es) 2024-03-08

Family

ID=85413154

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2024002458A MX2024002458A (es) 2021-08-28 2022-08-28 Composicion de nebulizacion que comprende tiotropio y su metodo de administracion.

Country Status (3)

Country Link
CO (1) CO2024003736A2 (fr)
MX (1) MX2024002458A (fr)
WO (1) WO2023031753A2 (fr)

Also Published As

Publication number Publication date
CO2024003736A2 (es) 2024-04-18
WO2023031753A2 (fr) 2023-03-09

Similar Documents

Publication Publication Date Title
PH12022551454A1 (en) Pyrazolyl derivatives useful as anti-cancer agents
WO2020106647A3 (fr) Polythérapie comprenant un inhibiteur de krasg12c et un ou plusieurs principes pharmaceutiquement actifs supplémentaires pour le traitement de cancers
SG10201902429PA (en) Combination therapy including an mdm2 inhibitor and one or more additional pharmaceutically active agents for the treatment of cancers
ZA202304064B (en) Quinoline cgas antagonist compounds
WO2018165404A8 (fr) Formulations pharmaceutiques de phloroglucinol et de triméthylphloroglucinol
MX2020013785A (es) Derivado de la pirido-pirimidina, metodo de preparacion del mismo y uso medico del mismo.
MX2023008333A (es) Nanomateriales.
MX2023003448A (es) Composicion farmaceutica que comprende conjugado de anticuerpo-farmaco y uso de la misma.
AU2019375825A8 (en) Macrocyclic tyrosine kinase inhibitor and uses thereof
MX2025000643A (es) Nanomateriales que comprenden trioles
ZA202308388B (en) Nasal compositions comprising alcaftadine
WO2023201299A8 (fr) Compositions pharmaceutiques de protéines thérapeutiques et procédés d'utilisation
MX2024010674A (es) Compuestos de quinolina antagonistas de cgas.
MX2025001990A (es) Agente terapeutico y metodo terapeutico que son para pacientes con cancer que presentan deterioro funcional de la proteina del retinoblastoma (rb1) y que implican el uso concomitante de inhibidor del factor de transcripcion 1 de mielina (myt1) y agente quimioterapeutico
WO2022081310A3 (fr) Médicaments inhalés inhibiteurs de pde-v
MX2023003089A (es) Formas farmaceuticas solidas de bacterias.
MX2024002458A (es) Composicion de nebulizacion que comprende tiotropio y su metodo de administracion.
MX2020000009A (es) Nuevas formulaciones en capsulas de gelatina blandas de secnidazol y sus usos.
GEP20227384B (en) Topical formulations comprising strontium and methylsulfonylmethane (msm) and methods of treatment
WO2022272036A9 (fr) Inhibiteurs de tead et leurs utilisations
EP4121038A4 (fr) Compositions et méthodes pour le traitement d'une infection à coronavirus et d'un compromis respiratoire
EA200970537A1 (ru) Антибактериальные производные хинолина
MX2020009711A (es) Combinacion de quinolin-4-carboxamidas y derivados de benzonaftiridina como combinacion de farmacos antipaludicos.
MX2024007944A (es) Derivados de 4-fenil-tetrahidropiridina para el tratamiento de enfermedades auditivas.
MX2022011565A (es) Derivados de acido boronico y usos terapeuticos de los mismos.